...
首页> 外文期刊>The American Surgeon >Synchronous Right Trisegmentectomy and Gastrectomy for Huge Hepatic Metastasis as First Manifestation of Advanced Gastric Cancer
【24h】

Synchronous Right Trisegmentectomy and Gastrectomy for Huge Hepatic Metastasis as First Manifestation of Advanced Gastric Cancer

机译:同步右三段切除术和胃切除术治疗巨大肝转移是晚期胃癌的首发表现

获取原文
获取原文并翻译 | 示例
           

摘要

In a series of 4370 patients with gastric cancer, 5 per cent developed liver metastasis (synchronous and metachronous); among this group, only 10 per cent were resectable.2 Hepatic resection has been reported as effective therapy for metastatic colorectal cancer3 with a 5-year survival rate from 30 to 50 per cent.4 On the contrary, in the case of liver metastases for gastric cancer, also in the absence of incurable factors, the effectiveness of hepatic resection is still widely debatable because of the presence of the multiple bilobar metastases with a 5-year survival rate from 0 to 38 per cent.2-4 In the last years, many studies have reported a small select number of cases with long-term survival (3 to 17 years) after surgical treatment of synchronous and metachronous liver metastases from gastric cancer.1-4 The authors that reported cases of gastric cancer with synchronous liver metastases (as we showed in our article) recorded a long survival rate after hepatic curative resection for patients with an early gastric lesion or single liver metastases from 1.5 to 1.7 cm in maximum diameter.1 Moreover, some authors showed a 17-year survival rate after curative gastric and hepatic resection in a patient with single liver metastases 2 to 5 cm in diameter.4 The authors performed limited hepatic resection because of the number (solitary liver metastases) and the dimension of the lesion; they also reported cases with repeated hepatic resection that were disease-free at 5-year follow up.4 A multivariate analysis from Ueada et al. demonstrated that an RO minor liver resection for solitary and small (1.5 to 2.5 cm) repetitive lesions are independent prognostic factors in the surgical treatment for synchronous liver metastases from gastric cancer. 1 In another study, Sakamoto et al. found at multivariate analysis that the number (solitary or multiple) of hepatic lesions and the maximum tumor size (less than 5 cm or larger) were independent prognostic factors.2 In our case, the primitive gastric lesion was not an early tumor (pT2b) with pNO and the two synchronous hepatic lesions were 16 and 20 cm.
机译:在一系列4370例胃癌患者中,有5%的患者发生了肝转移(同步和异时)。在这一组中,只有10%可以切除。2据报道,肝切除术是转移性结直肠癌的有效疗法3,其5年生存率从30%到50%。4相反,对于肝转移,胃癌,即使在没有不可治愈的因素的情况下,肝切除的有效性仍然存在广泛争议,因为存在多处双叶转移,其5年生存率从0%到38%。2-4 ,许多研究报告了少数经胃癌同步和异时肝转移瘤手术治疗后具有长期生存(3至17年)的病例。1-4报告胃癌并发肝转移的病例的作者(正如我们在文章中所显示的),对于具有早期胃病灶或最大直径从1.5到1.7 cm的单一肝转移的患者,肝切除术后的长期生存率很高。1此外,我的作者显示,对于直径为2至5 cm的单发肝转移的患者,根治性胃和肝切除术后17年生存率。4作者进行了有限的肝切除,原因是其数目(孤立性肝转移)和大小病变他们还报告了在5年的随访中无肝切除的反复肝切除病例。4Ueada等人的多变量分析。结果表明,在胃癌同步性肝转移的外科手术治疗中,对于单个和小的(1.5至2.5 cm)重复性病变,进行RO小肝切除是独立的预后因素。 1在另一项研究中,Sakamoto等人。在多因素分析中发现,肝病变的数量(单个或多个)和最大肿瘤大小(小于5 cm或更大)是独立的预后因素。2在我们的病例中,原始胃病变不是早期肿瘤(pT2b)与pNO和两个同步肝病变分别为16和20厘米。

著录项

  • 来源
    《The American Surgeon》 |2009年第7期|p.629-630|共2页
  • 作者单位

    Address correspondence and reprint requests to Paolo Aurelio, M.D., Ph.D., University of Rome "La Sapienza," 11° Faculty of Medicine, Sant' Andrea Hospital, Surgery Unit "D," Via Cairano, 6 00177 Rome, Italy E-mail: paolo_aurello@yahoo.it.Paolo Aurelio, M.D., Ph.D.Riccardo Bellagamba, M.D.Francesco D'Angelo, M.D., Ph.D.Claudia Cicchini, M.D., Ph.D.Giuseppe Nigri, M.D. Ph.D.Matteo Ravaioli, M.D.Giovanni Ramacciato, M.D.University of Rome "La Sapienza"II° Faculty of MedicineSant'Andrea HospitalSurgery Unit "D"Via di Grottarossa, 1035-3900189 Rome, Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号